InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,732.93
(
0.25%
)
US TECH 100
19,426.40
(
0.54%
)
Dow Jones
42,208.22
(
0.20%
)
Brent Oil
74.56
(
1.11%
)
Bitcoin
64,159.51
(
1.31%
)
Post# of 43369
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

whytestocks

Send PM Follow Ignore
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

whytestocks

Re: None

Friday, 05/31/2019 2:40:41 PM

Friday, May 31, 2019 2:40:41 PM

Post# of 43369
News: $HGEN Kite and Humanigen Announce Clinical Collaboration to Evaluate Investigational Combination of Yescarta® (Axicabtagene Ciloleucel) with Lenzilumab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

-- Phase 1/2 Multi-Center Clinical Trial to Begin Enrolling in Q4 2019 -- Kite, a Gilead Company (Nasdaq: GILD), and Humanigen, Inc. (HGEN) announced today the formation of a clinical collaboration to conduct a Phase 1/2 study of lenzilumab, an investigational anti-GM-CSF monoclon...

In case you are interested https://marketwirenews.com/news-releases/kite-and-humanigen-announce-clinical-collaboration-to-evaluate-investigational-combination-of-yescarta-xae-axicabtagene-ciloleucel-with-lenzilumab-in-relapsed-refractory-diffuse-large-b-cell-lymphoma-8277292.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up